SeaCrest Wealth Management’s IGC Pharma IGC Stock Holding History

SeaCrest Wealth Management’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2	Closed	–	–	1126
2019 Q1	$0	Buy	+2	New	+$5	﹤0.01%	2179

Other funds holding IGC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CFA

Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SeaCrest Wealth Management's IGC Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of IGC Pharma (IGC) in Q2 2019, closing a stake of 2 shares.

SeaCrest Wealth Management first reported a position in IGC in Q1 2019 and held it in 1 quarter. The position peaked at $0 in Q1 2019. 31 funds tracked by Wall St. Rank hold IGC as of Q2 2019.

SeaCrest Wealth Management reported no remaining IGC Pharma position as of Q2 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 2 IGC Pharma shares in Q2 2019.
SeaCrest Wealth Management first reported a position in IGC Pharma in Q1 2019 and held it in 1 quarter.
SeaCrest Wealth Management's IGC Pharma position peaked at $0 in Q1 2019.
31 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.